Camparo P, Vasiliu V, Molinie V, et al. Renal translocation carcinomas: clinicopathologic, immunohistochemical, and gene expression profiling analysis of 31 cases with a review of the literature. Am J Surg Pathol. 2008 May. 32(5):656-70. [Medline].
Argani P, Ladanyi M. Translocation carcinomas of the kidney. Clin Lab Med. 2005 Jun. 25(2):363-78. [Medline].
Wu A, Kunju LP, Cheng L, Shah RB. Renal cell carcinoma in children and young adults: analysis of clinicopathological, immunohistochemical and molecular characteristics with an emphasis on the spectrum of Xp11.2 translocation-associated and unusual clear cell subtypes. Histopathology. 2008 Nov. 53(5):533-44. [Medline].
Bruder E, Passera O, Harms D, et al. Morphologic and molecular characterization of renal cell carcinoma in children and young adults. Am J Surg Pathol. 2004 Sep. 28(9):1117-32. [Medline].
Geller JI, Argani P, Adeniran A, et al. Translocation renal cell carcinoma: lack of negative impact due to lymph node spread. Cancer. 2008 Apr 1. 112(7):1607-16. [Medline].
Selle B, Furtwangler R, Graf N, Kaatsch P, Bruder E, Leuschner I. Population-based study of renal cell carcinoma in children in Germany, 1980-2005: more frequently localized tumors and underlying disorders compared with adult counterparts. Cancer. 2006 Dec 15. 107(12):2906-14. [Medline].
Altinok G, Kattar MM, Mohamed A, Poulik J, Grignon D, Rabah R. Pediatric renal carcinoma associated with Xp11.2 translocations/TFE3 gene fusions and clinicopathologic associations. Pediatr Dev Pathol. 2005 Mar-Apr. 8(2):168-80. [Medline].
Ramphal R, Pappo A, Zielenska M, Grant R, Ngan BY. Pediatric renal cell carcinoma: clinical, pathologic, and molecular abnormalities associated with the members of the mit transcription factor family. Am J Clin Pathol. 2006 Sep. 126(3):349-64. [Medline].
Argani P, Olgac S, Tickoo SK, et al. Xp11 translocation renal cell carcinoma in adults: expanded clinical, pathologic, and genetic spectrum. Am J Surg Pathol. 2007 Aug. 31(8):1149-60. [Medline].
Argani P. The evolving story of renal translocation carcinomas. Am J Clin Pathol. 2006 Sep. 126(3):332-4. [Medline].
Argani P, Lae M, Ballard ET, et al. Translocation carcinomas of the kidney after chemotherapy in childhood. J Clin Oncol. 2006 Apr 1. 24(10):1529-34. [Medline].
He H, Zhou GX, Zhou M, et al. The distinction of clear cell carcinoma of the female genital tract, clear cell renal cell carcinoma, and translocation-associated renal cell carcinoma: an immunohistochemical study using tissue microarray. Int J Gynecol Pathol. 2011 Sep. 30(5):425-30. [Medline].
Argani P, Antonescu CR, Illei PB, et al. Primary renal neoplasms with the ASPL-TFE3 gene fusion of alveolar soft part sarcoma: a distinctive tumor entity previously included among renal cell carcinomas of children and adolescents. Am J Pathol. 2001 Jul. 159(1):179-92. [Medline].
Argani P, Antonescu CR, Couturier J, et al. PRCC-TFE3 renal carcinomas: morphologic, immunohistochemical, ultrastructural, and molecular analysis of an entity associated with the t(X;1)(p11.2;q21). Am J Surg Pathol. 2002 Dec. 26(12):1553-66. [Medline].
Gobbo S, Eble JN, Grignon DJ, et al. Clear cell papillary renal cell carcinoma: a distinct histopathologic and molecular genetic entity. Am J Surg Pathol. 2008 Aug. 32(8):1239-45. [Medline].
Argani P, Hawkins A, Griffin CA, et al. A distinctive pediatric renal neoplasm characterized by epithelioid morphology, basement membrane production, focal HMB45 immunoreactivity, and t(6;11)(p21.1;q12) chromosome translocation. Am J Pathol. 2001 Jun. 158(6):2089-96. [Medline].
Argani P, Lal P, Hutchinson B, Lui MY, Reuter VE, Ladanyi M. Aberrant nuclear immunoreactivity for TFE3 in neoplasms with TFE3 gene fusions: a sensitive and specific immunohistochemical assay. Am J Surg Pathol. 2003 Jun. 27(6):750-61. [Medline].
Zhong M, Haberman J, Andrews N, e al. Xp11.2 translocation renal cell carcinoma in adults--a TMA study of 120 RCC cases. Mod Pathol. 2009. 22:203A.
Kim SH, Choi Y, Jeong HY, et al. Usefulness of a break-apart FISH assay in the diagnosis of Xp11.2 translocation renal cell carcinoma. Virchows Arch. 2011 Sep. 459(3):299-306. [Medline].
Martignoni G, Pea M, Gobbo S, et al. Cathepsin-K immunoreactivity distinguishes MiTF/TFE family renal translocation carcinomas from other renal carcinomas. Mod Pathol. 2009 Aug. 22(8):1016-22. [Medline].
Eble JN, Sauter G, Epstein JI, Sesterhenn IA, eds. Pathology and Genetics of Tumours of the Urinary System and Male Genital Organs. Lyon, France: IARC Press; 2004. [Full Text].
Medendorp K, van Groningen JJ, Schepens M, et al. Molecular mechanisms underlying the MiT translocation subgroup of renal cell carcinomas. Cytogenet Genome Res. 2007. 118(2-4):157-65. [Medline].
Malouf GG, Su X, Yao H, et al. Next-generation sequencing of translocation renal cell carcinoma reveals novel RNA splicing partners and frequent mutations of chromatin-remodeling genes. Clin Cancer Res. 2014 Aug 1. 20(15):4129-40. [Medline].
Greene FL, Page DL, Fleming ID et al. eds. AJCC Cancer Staging Manual. New York, NY: Springer; 2002.
Ishihara A, Yamashita Y, Takamori H, et al. Renal carcinoma with (6;11)(p21;q12) translocation: Report of an adult case. Pathol Int. 2011 Sep. 61(9):539-45. [Medline].
Rais-Bahrami S, Drabick JJ, De Marzo AM, et al. Xp11 translocation renal cell carcinoma: delayed but massive and lethal metastases of a chemotherapy-associated secondary malignancy. Urology. 2007 Jul. 70(1):178.e3-6. [Medline].
Dal Cin P, Stas M, Sciot R, De Wever I, Van Damme B, Van den Berghe H. Translocation (X;1) reveals metastasis 31 years after renal cell carcinoma. Cancer Genet Cytogenet. 1998 Feb. 101(1):58-61. [Medline].
Marchionni L, Hayashi M, Guida E, et al. MicroRNA expression profiling of Xp11 renal cell carcinoma. Hum Pathol. 2017 Apr 11. [Medline].
Xp11.2 translocation-associated renal cell carcinomas are generally cortical or subcapsular, well-circumscribed lesions with yellow-tan, variegated cut surfaces. Image courtesy of University of Michigan.
